Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 1Phase 1 1

Status

Terminated 2Completed 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Urinary Bladder Neoplasms 13Colorectal Neoplasms 9Neoplasm Metastasis 8Peritoneal Neoplasms 6Pancreatic Neoplasms 6Non-Muscle Invasive Bladder Neoplasms 6Appendiceal Neoplasms 6Stomach Neoplasms 5Carcinoma, Hepatocellular 5Anus Neoplasms 5Sarcoma 4Rectal Neoplasms 4Colonic Neoplasms 4Liver Neoplasms 3Carcinoma, Transitional Cell 3Pseudomyxoma Peritonei 2Mesothelioma, Malignant 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Anal Canal Carcinoma 2Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pleural Neoplasms 1Pancoast Syndrome 1

Interventions

Gemcitabine 295Fluorouracil 82Oxaliplatin 81130-nm albumin-bound paclitaxel 68Capecitabine 60Leucovorin 56Albumin-Bound Paclitaxel 54Radiotherapy 51Irinotecan 44Taxes 37Cisplatin 36Erlotinib Hydrochloride 34Radiosurgery 33pembrolizumab 29Docetaxel 27S 1 (combination) 26Bevacizumab 23folfirinox 22Nivolumab 21Magnetic Resonance Spectroscopy 17Cyclophosphamide 17Cetuximab 17irinotecan sucrosofate 16Radiation 16Drug Therapy 15Surgical Procedures, Operative 14Specimen Handling 11Biopsy 11durvalumab 10Paclitaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Pancreatic Neoplasms × Mitomycin × Clear all
NCT01905150 2024-12-11

Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

Bruckner Oncology

Phase 2 Completed
34 enrolled 10 charts
Gastrointestinal

Pancreatic Neoplasms

NCT06233877 2024-02-28

GFLIPM

Hirschfeld Oncology

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00276744 2018-10-24

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
249 enrolled 4 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00386399 2018-07-12

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT00003018 2013-01-03

S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer

SWOG Cancer Research Network

Phase 2 Completed
54 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00967291 2012-02-01

PACT-11

IRCCS San Raffaele

Phase 2 Terminated
21 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡